Anixa Biosciences (ANIX) Accounts Payables (2010 - 2026)
Anixa Biosciences (ANIX) reported Accounts Payables of $282,000 for fiscal Q3 2026 (quarter ended Jul 31, 2026), up 2.2% from $276,000 a year earlier and up 11.9% from the prior quarter.
Powered by 
Analysis
Anixa Biosciences (ANIX) Accounts Payables (2010 - 2026) Analysis & Trends
At the end of FY2025 (ended Oct 31, 2025), Anixa Biosciences posted Accounts Payables of $165,000, down 68.6% from FY2024.
- Accounts Payables has a five-year compound annual growth rate of -6.6% (FY2020 to FY2025).
- By fiscal year, Accounts Payables came in at $525,000 in FY2024 (+154.9%), $206,000 in FY2023 (-22.3%), $265,000 in FY2022 (+94.9%) and $136,000 in FY2021 (-41.5%).
- The fiscal Q3 2026 figure ranks as the highest quarterly Accounts Payables since fiscal Q2 2025.
- Year over year, Accounts Payables gained in four of the last seven quarters, with growth averaging 23.6%.
- The high point for year-over-year Accounts Payables in five years was fiscal Q1 2024 (growth of 230.9%); the low point was fiscal Q2 2022 (a decline of 78.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Anixa Biosciences | 101.33 Mn | 100.06 Mn | - | 282,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 282,000.00 |
| Apr 30, 2026 | 252,000.00 |
| Oct 31, 2025 | 165,000.00 |
| Jul 31, 2025 | 276,000.00 |
| Apr 30, 2025 | 284,000.00 |
| Jan 31, 2025 | 600,000.00 |
| Oct 31, 2024 | 525,000.00 |
| Jul 31, 2024 | 302,000.00 |
| Apr 30, 2024 | 215,000.00 |
| Jan 31, 2024 | 364,000.00 |
| Oct 31, 2023 | 206,000.00 |
| Jul 31, 2023 | 94,000.00 |
| Apr 30, 2023 | 195,000.00 |
| Jan 31, 2023 | 110,000.00 |
| Oct 31, 2022 | 265,000.00 |
| Jul 31, 2022 | 227,000.00 |
| Apr 30, 2022 | 93,000.00 |
| Jan 31, 2022 | 504,000.00 |
| Oct 31, 2021 | 136,000.00 |
| Jul 31, 2021 | 207,733.00 |
API Access
Anixa Biosciences Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=ANIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "ANIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=ANIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();